Evaluation of the effects of L-carnitine on liver function after liver transplantation

Tehran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新: 2018年9月11日

适应症

试验速览

暂无简介。

•All patients over 14 years old with liver cirrhosis who are candidate for the first liver transplantation on the liver transplant list of Imam Khomeini Hospital Complex
•Patient's consent to enter the study

•Children under the age of 14 years who are candidate for liver transplantation
•Patients candidate for liver re-transplantation
•Patients who are candidate for liver transplant due to acute liver failure
•Patients undergoing simultaneous multiple organ transplantations (simultaneous liver-kidney transplantation, simultaneous liver-pancreas-kidney transplantation)
•Patients undergoing split liver transplantation from living donors or deceased donors
•Pregnant or lactating women
•History of allergy to L-Carnitine
•Patients with a history of seizure
•Patients with postoperative unstable conditions such as fever, sepsis, and shock, Cardiac instability (ACS/MI), gastrointestinal bleeding, long-term need for vasopressor (norepinephrine at doses greater than 0.5 µg/kg/min)

发起方